[London, 6 June 2024] – With deep, hassle-free, integration, Augnito is enabling continued transformation in radiology and supporting key solutions that will be showcased at UKIO 2024.

Taking place from 10th-12th June 2024 in Liverpool, the UK Imaging and Oncology (UKIO) congress is where leaders from across radiology come together to share best practice, discuss trends, undertake professional development, and learn about the latest state-of-the-art equipment and technology. The 2024 event will focus on the theme of ‘Vision and Values: Putting People First’.

Thanks to robust partnerships and extensive integration with leading platforms, Augnito speech recognition from Scribetech will be present at the event for the fourth year running.

“Nothing is more important to us than elevating fields across healthcare, and radiology is a particular focus,” stated Shiraz Austin, Managing Director at Scribetech (UK) Ltd and Co-Founder of Augnito. “Augnito Spectra, our own highly convenient frontend across desktop and mobile, is part of this approach, but integration is equally important. Technology providers understand the potential of speech recognition as an accessible way for healthcare to leverage the potential of AI. Our partnerships with award-winning providers using Augnito Voice Services to speech enable their platforms is key to how, together, we can bring the benefits of speech recognition to more radiologists.”

One of the solutions carrying Augnito Voice Services embedded inside is Intelerad’s InSight PACS,  adopted by over 250 NHS and private healthcare providers across the UK and Ireland. In February 2024, InSight PACS was recognised as a 2024 Best in KLAS: Global Software Report award winner. Crucially, this award was based on feedback from the solution’s users – the people who rely on radiology reporting technology every day.

Austin stated: “Clinical system developers and cloud imaging solution providers appreciate Augnito for its API and SDK allowing them to seamlessly add Voice Services to their offering. We’ve taken one-of-a-kind speech recognition, developed in partnership with clinicians, and made it easy to integrate into any existing diagnostics and radiology reporting platform. But what drives us is the response from radiologists. People have reported significant time savings, faster reports, and increased accuracy – all these benefits lead to smoother patient journeys and better outcomes. That’s what matters.”

Augnito is also integrated into Hexarad: Radiology Technology Innovator of the Year in the M&A Today Global Awards 2024. Hexarad was also awarded the Silver HSJ Partnership Award for Diagnostics Project of the Year for its partnership with the North West Anglia NHS Foundation Trust. This project led to estimated time savings of up to 80 minutes per patient. Meanwhile, teleradiologists reporting on behalf of the trust received images within 25 minutes compared to 45 minutes using the previous system.

Representatives from these leading imaging solutions award winners will be attending UKIO 2024, (Hexarad), and exhibiting (Intelerad) alongside other high profile Scribetech partners using Augnito to speech-enable their systems. Exhibitors include Aptvision Ltd – with their e-referral portal, delivering better patient outcomes and reducing workloads for medical staff, CIMAR UK Ltd – who has recently joined forces with NHS England to deliver the AI Development Platform Pilot at Royal Surrey NHS Foundation Trust that will then enable the deployment of AI in medical imaging across the NHS, Fujifilm Healthcare UK – has integrated Augnito into its Universal Reporting module and will be showing this at UKIO, as well as new ultrasound imaging innovations and live demonstrations on its DeepInsight AI technology, Magentus – with a new Managing Director at their UK helm and a team supporting more than 25 million imaging events each year across 700+ locations with its Cris Radiology Information System, and OpenRad Services UK Ltd – showcasing its cloud-based Augnito speech-enabled remote reporting platform that includes the functionalities of a PACS, RIS and diagnostic 3D visualisation as distinct subscription packages with secure access from anywhere and from any device.

This significant presence at UKIO reflects the continued growth of Augnito AI powered speech recognition across radiology.

Scribetech is also a member of AXREM, the UK trade association for suppliers of imaging and healthcare equipment. This gives the company insight into the current and emerging needs of radiologists and imaging professionals and helps ensure that its voice-driven AI powered and cloud based solution, Augnito, remains relevant, impactful and evolving in pace with demand.

“This will be the fourth year running, since launching Augnito technology, that it is being shown at UKIO through our partners,” added Austin. “And while Scribetech has been an approved NHS solutions provider for over two decades, we brought Augnito to the UK market as a disruptive technology because our vision was to democratise the use of speech recognition across the continuum of care. We knew Augnito provided the value advantage – a better and more cost effective way for healthcare professionals to leverage the cloud and AI, to easily transform their patient data workflows. Now, 30 months later, we’re supporting more than 2,000 UK radiologists who have switched to Augnito – through our partnerships – and many others directly. We couldn’t agree more with this year’s UKIO theme and message ‘Vision and Values: Putting People First’. The positive effect that the impact Augnito is having on radiologists, and on patient imaging and diagnostics reporting speaks for itself. ”

ENDS

For media enquiries, please contact [email protected]

Notes to editors
All company names and product names listed in this press release are trademarks and registered trademarks of their respective owners.

About Scribetech (UK) Ltd and Augnito
Scribetech (UK) Ltd is a clinical solutions innovator and official distributor of Augnito products in the UK and Ireland. The company co-developed Augnito with its sister company Augnito India Private Ltd fusing 20 years of highly accurate and secure transcription and digital dictation services to the NHS, speech-to-text, and clinical coding solutions for the healthcare sector, and its own Deep Neural Network speech recognition engine with advanced voice AI technology. Augnito provides a secure, cloud-based, voice-driven AI clinical speech recognition product suite, offering fast, easy ways to capture live clinical data on any device with 99% accuracy, support for multiple medical specialities, and no need for voice profile training. Augnito brings cost effective, seamless speech recognition to daily workflows and third-party clinical systems, quickly turning medical information into documentation that makes healthcare intelligence compliant and accessible where it is needed.

[London, 30 June 2023] – Scribetech has been dramatically expanding its ecosystem of Augnito partnerships and successful integrations in order to empower more healthcare professionals with clinical documentation flexibility and a more efficient way of working.

Efficient clinical speech/voice-to-text digital dictation technology has the potential to improve clinical workflows, reduce delayed patient journeys and enable better informed outcomes. Such technology is only as effective as it is accessible, easy to adopt, easy to integrate, and easy to use.

To this end Scribetech (UK) Ltd, co-creator of Augnito, has invested in a new ecosystem of distributors, value added resellers and integration partners to help bring its AI-powered speech recognition technology to more users across the UK, starting with the new channel’s customers.

In the past three months, companies have been onboarded as distributors for Augnito Spectra – a cloud-based clinical speech recognition solution that supports any English accent, out of the box. This recent UK activity follows successful agreements with resellers in the last quarter. In addition, integration partners including Aptvision, OpenRad and Intelerad have recently integrated Augnito Voice Services into their own radiology reporting platforms, bringing higher levels of accuracy and the time-saving advantage of speech to the systems their respective medical customers already use.

This recent success aligns with Augnito’s sales and development team’s core strategy, reflecting not only a strong 2-year track record in delivering measurable savings and benefits to healthcare, but also reiterating the premier service-oriented heritage it carries from its co-developer’s solution support to the NHS in the last two decades.

More than 12,000 doctors across 355 hospitals and 24 partners in UK, USA, Canada, India, the Middle East and APAC, have signed up to Augnito in just 24 months. They are joined by 1500 radiologists and a growing number of consultants at various NHS Trusts. “Everything comes back to the mission we set out when we launched Augnito in the UK in late 2021,” stated Shiraz Austin, Managing Director at Scribetech (UK) Ltd and Co-Founder of Augnito.

“We know that when access to technology is simplified from the ground up, even small increases in performance turn into huge savings. Those savings can be repurposed into what matters most – making healthcare professionals efficient at delivering exceptional care and improving patient outcomes.”

Interoperability and integration are both key to this important goal. Through Augnito Voice Services and a flexible API/SDK, healthcare technology providers can integrate speech recognition into their own platforms in a matter of weeks. To date, Cimar UK, Hexarad, Fujifilm UK Medical Systems and Magentus have all integrated Augnito technology into their radiology systems, enabling efficient workflows for their customers with more accurate diagnostic reporting.

Augnito Spectra gives users constant access to accurate speech recognition and live data input on any device running either Windows or MAC operating systems. This data is then routed securely to clinical systems including PACS and EPRs. Augnito’s ability to fit into existing clinical workflows makes user adoption easier and effective. It reduces both workload management and costs, as well as changing the way providers deploy new technology – ground up vs. top down.

Austin added: “Through our best-in-breed partnerships, we’re introducing real product flexibility and agility to assist medical health professionals in providing better patient journeys. We’ve been proactive in creating more ways to use Augnito, helping us align to the NHS plan for digital transformation and ensure new technology is integrated in a way that will naturally drive user adoption.”

For IT and technology providers in healthcare, Augnito Spectra carries a compelling (up to) 30% profit margin on every UK licence the partner sells. It is designed to be easy and fast to deploy and looks to complement partners’ existing product portfolios and service offerings. For partners’ users, Augnito Spectra provides simpler and more accurate clinical data input into all major EPR systems.

Austin concluded: “We’ve seen significant demand from resellers because the demand is there across healthcare. Inefficiencies and reporting bottlenecks are costing millions of pounds in Delayed Transfer of Care (DTOC) and bed costs as well as the ever growing patient waiting lists. And with rising demand and intense workloads, everyone inside a Trust knows something needs to change. The healthcare user benefits and the time and financial savings are significant from day one. In fact the cost of Augnito per day is less than a takeaway coffee.”

ENDS

Notes to editors

About Augnito and Scribetech
Augnito is a secure, cloud-based, AI-driven clinical speech recognition product suite. It offers fast, easy ways to capture live clinical data on any device with 99% accuracy, support for multiple medical specialities, and no need for voice profile training. Augnito brings seamless speech recognition to daily workflows and third-party clinical systems, turning medical information into clinical documentation and making healthcare intelligence securely accessible everywhere.

Augnito was co-developed by Scribetech, a clinical voice solutions innovator, fusing 20 years of transcription and digital dictation services to the NHS, speech-to-text, and clinical coding solutions for the healthcare sector, and its own speech recognition engine with advanced voice AI technology.

[London, 18 May 2023] – Augnito Voice Services™ will integrate with Intelerad’s InSight PACS reporting, equipping clients with accessible, advanced speech recognition technology that simplifies patient care.

This new integration partnership will provide Intelerad clients with increased voice recognition options, giving them access to a pioneering, cloud-based product that helps ensure clients are not limited to one voice recognition platform and the risks associated with that dependence.
Intelerad Cloud is a menu of expertly cloud-engineered solutions designed to optimise the benefits of Cloud technology and scalability potential without sacrificing the performance of onsite architecture. Proudly vendor-neutral, Intelerad, is integrating its products with multiple technologies which fit with its cloud-based strategy, Augnito being the most recent. These can assist with the Cloud First strategy by utilising the Cloud for disaster recovery, image exchange and long-term archiving, and this latest addition is another way Intelerad is providing the latest cloud innovations and future resilience required by its clients.

Augnito can be used with a speech microphone or even through an app on a smartphone, making it faster and easier for radiologists and clinicians to diagnose critical conditions where every second counts, leading to better outcomes for patients.

Shiraz Austin, Managing Director at Scribetech (UK) Ltd and Co-Founder of Augnito stated, “Intelerad is a best-in-class provider of medical imaging software with a mission statement that dovetails very well into our own – where technology is developed to impact healthcare in a positive way and where making more time for patient care is paramount. Our partnership agreement solidifies the solution strategies of both organisations, and we’re excited that our secure, cloud-based, voice-powered AI speech recognition technology, Augnito, will play an important role in achieving this. Through the use of Augnito technology, Intelerad can empower radiologists to deliver reporting when and where it’s needed to keep the patient journey and clinical workflows moving.”

Intelerad is exploring integrating Augnito into other products in its portfolio, Arron Edwards, Managing Director of Intelerad, commented, “Intelerad is excited to be able to add the class-leading, cloud-based speech engine from Augnito into our fully featured rich reporting solution, which is built into InSight PACS. Our UK engineering team have worked hand-in-hand with the Augnito engineering team at Scribetech, leading to an incredibly successful integration which will ensure that we can continue to offer a best-in-class solution for our clients.”

ENDS
For further information, please contact:
Clare Dawe, Marketing Manager, Insignia Medical Systems powered by Intelerad
01256 247 010
[email protected]

ABOUT INTELERAD
Intelerad is one of the leading providers of medical imaging software and services for the healthcare industry. Headquartered in Raleigh, NC and Montreal, Quebec, Intelerad has over 900 employees located in offices across six countries. Nearly 2,500 healthcare organizations around the world rely on Intelerad products to manage patient data, helping them reduce time and workload while improving patient outcomes. Intelerad’s award-winning enterprise imaging solutions have been recognized globally by KLAS, with Intelerad’s Ambra Health ranked #1 in Image Exchange for eight consecutive years. To learn more, visit intelerad.com.

Intelerad welcomes contact from PRs and journalists for quotes, expert opinions or bespoke content for particular press articles. Please contact Clare Dawe in the first instance at [email protected]

ABOUT SCRIBETECH AND THE AUGNITO SOLUTION
Augnito is a secure, cloud-based, AI-driven clinical speech recognition product suite. It offers fast, easy ways to capture live clinical data on any device with 99.3% accuracy, support for multiple medical specialties, and no need for voice profile training. Augnito brings seamless speech recognition to daily workflows and third-party clinical systems, turning medical information into clinical documentation and making healthcare intelligence securely accessible wherever it’s needed. Augnito was co-developed by Scribetech, a clinical voice solutions innovator, fusing 20 years of transcription and digital dictation services to the NHS, speech-to-text, and clinical coding solutions for the healthcare sector, and its own speech recognition engine with advanced voice AI technology. Follow us on Linked-In.